adenine has been researched along with Aplasia Pure Red Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arslan, S | 1 |
| Ali, H | 1 |
| Mei, M | 1 |
| Marcucci, G | 1 |
| Forman, S | 1 |
| Nakamura, R | 1 |
| Stein, A | 1 |
| Al Malki, MM | 1 |
| Hochman, MJ | 1 |
| Martin, DB | 1 |
| Krečak, I | 1 |
| Čengić, M | 1 |
| Skorić, I | 1 |
| Nakić, M | 1 |
| Gverić-Krečak, V | 1 |
| Goldschmidt, N | 1 |
| Rund, D | 1 |
4 other studies available for adenine and Aplasia Pure Red Cell
| Article | Year |
|---|---|
Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.
Topics: ABO Blood-Group System; Adenine; Blood Group Incompatibility; Hematopoietic Stem Cell Transplantatio | 2022 |
Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL.
Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, | 2021 |
Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
Topics: Adenine; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Female; Humans; Leukemia, Lymphocytic, Ch | 2021 |
Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib.
Topics: Adenine; Aged; Antineoplastic Agents; Biomarkers; Biopsy; Blood Cell Count; Female; Humans; Leukemia | 2017 |